Benzo(c)quinolizinium drugs inhibit degradation of ΔF508-CFTR cytoplasmic domain
- 10 January 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 300 (2) , 524-530
- https://doi.org/10.1016/s0006-291x(02)02883-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Principal Role for the Proteasome in Endoplasmic Reticulum-associated Degradation of Misfolded Intracellular Cystic Fibrosis Transmembrane Conductance RegulatorPublished by Elsevier ,2002
- Quality Control by Proteases in the Endoplasmic ReticulumJournal of Biological Chemistry, 1998
- The Mechanism Underlying Cystic Fibrosis Transmembrane Conductance Regulator Transport from the Endoplasmic Reticulum to the Proteasome Includes Sec61β and a Cytosolic, Deglycosylated IntermediaryJournal of Biological Chemistry, 1998
- Actions of adenosine A1 and A2 receptor antagonists on CFTR antibody‐inhibited β‐adrenergic mucin secretion responseBritish Journal of Pharmacology, 1998
- Nucleotidase Activities of the 26 S Proteasome and Its Regulatory ComplexJournal of Biological Chemistry, 1996
- The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the CytosolCell, 1996
- Altered protein folding may be the molecular basis of most cases of cystic fibrosisFEBS Letters, 1992
- Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia.Journal of Clinical Investigation, 1992
- Identification of the Cystic Fibrosis Gene: Genetic AnalysisScience, 1989
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989